Davita Sp. z o.o.

At Davita Sp. z o.o., research in female urogenital health explores conditions that affect women during pregnancy and reproductive years. The team aims to improve diagnosis and treatment strategies for disorders such as urinary tract infections and gestational complications.

• Pregnancy‑related hypertension
• Urinary tract infection management
• Pelvic organ prolapse evaluation

Although current trials focus on renal disease, the site plans to expand its portfolio to address these women's health challenges.

The primary research focus at Davita Sp. z o.o. is on anemia in patients with chronic kidney disease undergoing dialysis, including those with end‑stage kidney disease. Studies assess new intravenous agents to lower high‑sensitivity C‑reactive protein and reduce the risk of cardiovascular events, as well as compare erythropoiesis‑stimulating therapies for better hemoglobin control.

• Anemia management in dialysis
• Cardiovascular risk reduction
• Erythropoietin therapy comparisons

The findings aim to enhance patient outcomes by offering safer and more effective treatments for kidney‑related blood disorders.

Research in male urogenital health at Davita Sp. z o.o. includes investigations of conditions that impact urinary and reproductive function in men. Efforts are directed toward better understanding of disease mechanisms and developing therapeutic options.

• Benign prostatic hyperplasia studies
• Male infertility evaluation
• Urinary obstruction treatment

While the current trial portfolio is centered on renal anemia, the site’s multidisciplinary team is equipped to support future male urogenital studies.